Drugs + Money
Insys—Which Fought Cannabis Legalization—Now May Turn Itself Entirely Into a Cannabis Company
Insys—the pharmaceutical company investigated for its unethical fentanyl marketing tactics in the midst of ...
Tainted Pharma Company That Fought Legalization Applies to Sell “Marihuana”
On October 30, the DEA announced that Pharma company Insys Therapeutics filed in August for approval ...
Trump’s New Opioid Package Is Gift-Wrapped for Indivior—At What Cost?
[Christopher Moraff pens the DISPATCHES column for Filter.] On October 24, President Donald Trump signed ...
Misinformation About So-Called “Terrorist Drug” Dispelled in New Report
If you’re in the US, you may not have heard of captagon—an understudied synthetic ...
Infographic: Which States Have the Highest Rates of Opioid-Related Insurance Claims
The state-by-state concentration of health insurance claim lines associated with opioid “abuse” and dependence ...
Trump’s Attack on Universal Health Care Grabs Headlines—But Here’s the Real “$660 Million Hurdle”
President Trump has just penned an op-ed for USA Today, in which he rants against ...
A Cannabis Law Expert Explains Three Major Hurdles for the Industry
“That can’t be right, marijuana is legal here.” It’s a common refrain from would-be ...
In Defense of Juul, After the Latest Media Hit-Piece
The media frenzy against Juul, the US market leader in vaping products, is on ...
“More Like Retail Than Healing”—Can the Opioid Crisis Bring Health Equity to Our Medical System?
Fifteen years ago, with an EMT colleague and an armed police officer, I arrived ...
In 2018, the Temperance Movement Still Grips America
Our society—even some of its most progressive elements—vilifies alcohol. This stands in opposition to ...
